Literature DB >> 8106125

Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.

M Wu1, S M Brudzynski, G J Mogenson.   

Abstract

Effects of dopamine D1 and D2 receptor agonists (SKF 38393 and quinpirole, respectively) on locomotion were studied in two behavioural situations characterized by low and high level of exploratory locomotor activity. Administration of quinpirole bilaterally into the nucleus accumbens increased locomotor activity at the low initial level of activity and decreased locomotor activity at the high activity level, while the administration of SKF 38393 increased locomotor activity in both behavioural situations. It was concluded that quinpirole has differential effects on locomotion, depending on the initial level of activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106125     DOI: 10.1016/0361-9230(93)90206-q

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Effects of dopamine D2 agonist quinpirole on neuronal activity of anterior cingulate cortex and striatum in rats.

Authors:  Jian-Jia Huang; Chen-Tung Yen; Tzu-Lan Liu; Hen-Wai Tsao; Ju-Wei Hsu; Meng-Li Tsai
Journal:  Psychopharmacology (Berl)       Date:  2013-01-18       Impact factor: 4.530

2.  Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice.

Authors:  Daniel G Smith; Eleni T Tzavara; Janice Shaw; Susan Luecke; Mark Wade; Richard Davis; Craig Salhoff; George G Nomikos; Donald R Gehlert
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

3.  Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function.

Authors:  John J Byrnes; Nicole L Johnson; Lindsay M Carini; Elizabeth M Byrnes
Journal:  Psychopharmacology (Berl)       Date:  2013-01-13       Impact factor: 4.530

4.  Role of enkephalinergic brain structures in regulating motivated behavior in rats with lesioned serotoninergic neurons.

Authors:  N P Shugalev
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

5.  Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model.

Authors:  Deepthi Yedlapudi; Gnanada S Joshi; Dan Luo; Sokol V Todi; Aloke K Dutta
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

6.  Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.

Authors:  Hélène N David
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.